# Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis

> **NCT00989235** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 108 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Abatacept
- **DRUG:** Abatacept

## Key facts

- **NCT ID:** NCT00989235
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2011-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00989235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00989235, "Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00989235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*